rs1554020702
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001127671.2(LIFR):βc.1578delβ(p.Lys526AsnfsTer4) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,894 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001127671.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIFR | NM_001127671.2 | c.1578del | p.Lys526AsnfsTer4 | frameshift_variant | 11/20 | ENST00000453190.7 | NP_001121143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIFR | ENST00000453190.7 | c.1578del | p.Lys526AsnfsTer4 | frameshift_variant | 11/20 | 2 | NM_001127671.2 | ENSP00000398368 | P1 | |
LIFR | ENST00000263409.8 | c.1578del | p.Lys526AsnfsTer4 | frameshift_variant | 11/20 | 1 | ENSP00000263409 | P1 | ||
LIFR | ENST00000503088.1 | n.1741del | non_coding_transcript_exon_variant | 11/15 | 1 | |||||
LIFR | ENST00000506003.5 | c.17del | p.Lys6AsnfsTer4 | frameshift_variant, NMD_transcript_variant | 1/7 | 3 | ENSP00000426919 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460894Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726826
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Stuve-Wiedemann syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 26, 2017 | The p.Lys526AsnfsX4 (NM_002310.5 c.1578delA) variant in LIFR has not been previo usly reported in individuals with Stuve-Wiedemann syndrome and was absent from l arge population studies. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 526 and leads to a premature termination codon 4 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function o f the LIFR gene has been associated with Stuve-Wiedemann syndrome. In summary, a lthough additional studies are required to fully establish its clinical signific ance, the p.Lys526AsnfsX4 variant is likely pathogenic for Stuve-Wiedemann syndr ome in an autosomal recessive manner based on a predicted null effect. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 23, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 506000). This variant has not been reported in the literature in individuals affected with LIFR-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Lys526Asnfs*4) in the LIFR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LIFR are known to be pathogenic (PMID: 14740318). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.